St. Jude Progress
Your Future, Your Decision: Tigers VAX Now HPV Vaccination Student Ambassador Program
| Jan 26, 2023The St. Jude HPV Cancer Prevention Program and the University of Memphis created Tigers VAX Now, a student ambassador program to empower college students to advocate for HPV vaccination as cancer prevention among their peers.
- Your Future, Your Decision: Tigers VAX Now HPV Vaccination Student Ambassador Program
- Genetic predispositions can drive cancer but are not destiny for patients
- St. Jude scientists on the hunt for ‘holy grail’ cancer vulnerabilities
- Powerful Voices: Preventing HPV Cancers through Survivor Perspectives
- Childhood cancer genetics: A legacy of groundbreaking work drives St. Jude forward
St. Jude researchers answer COVID questions
| Jul 5, 2022St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.
Learn moreEmployee volunteers aid St. Jude contact tracing team in fight against COVID-19
| Sep 2, 2021The St. Jude Case Investigation and Contact Tracing Team has been working to keep the St. Jude campus safe during the COVID-19 pandemic.
Learn moreConnections with colleagues: A St. Jude pediatric psychologist has renewed appreciation for an overlooked benefit of interdisciplinary collaboration.
| Jul 5, 2021A pediatric psychologist expresses gratitude for interdisciplinary collaboration, which elevates patient care and provider well-being.
Learn moreCompassionate connections: Providing end-of-life care to patients and families during COVID-19
| Jul 1, 2021A St. Jude psychologist who provided supportive end-of-life care during the pandemic shares recommendations for making compassionate connections with patients and families.
Learn moreSAFER Ukraine offers a new model for global emergency response
| Sep 29, 2022SAFER Ukraine, a global humanitarian effort to save Ukrainian children with cancer and blood disorders began spontaneously in a digital meeting room within hours of the invasion. Existing networks fueled its growth.
Learn moreSAFER Ukraine: a framework for responding to global conflicts
| May 26, 2022What lessons can be learned from the remarkable success of SAFER Ukraine?
Learn moreA doctor’s journey fueled life-saving work at SAFER Ukraine for children with cancer
| May 12, 2022“SAFER Ukraine works because we have human connections with our partners,” explains Asya Agulnik, MD, MPH.
Learn moreMarcin Wlodarski, MD, PhD, dropped everything to help children fleeing Ukraine
| May 10, 2022Marcin Wlodarski, MD, PhD, was new to international humanitarian work prior to volunteering with SAFER Ukraine. “I learned so much I cannot every describe it in words,” he said.
Learn moreMath test points metastatic breast cancer treatment in the right direction
| Dec 30, 2022St. Jude computational biologists created a computational score predicting cancer drug sensitivity to HDAC6 inhibitors in a promising phase Ib clinical trial.
Learn moreOn the road to resistance: How bacteria can win the game of life ‘with a little help from their friends’
| Dec 15, 2022St. Jude scientists have learned that bacteria are more successful at developing antibiotic resistance when they swap genes through recombination.
Learn moreLatin American hospitals implement tool to identify kids whose condition is deteriorating
| Nov 1, 2022Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.
Learn moreNew model mimics progression of pediatric bone marrow failure
| Oct 4, 2022St. Jude scientists have created the first model that faithfully recapitulates details of pediatric bone marrow failure.
Learn moreDiagnostic Imaging receives hospital’s first Expanded Access use designation from FDA
| Dec 29, 2022St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.
Learn moreSt. Jude advice to young adults with sickle cell disease: Stay connected
| Nov 28, 2022The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.
Learn moreBy sharing their story, cancer patients can help improve their care
| Jun 16, 2022Narrative medicines uses insight gained from listening carefully to how patients tell their own stories to improve health care, patient education and research.
Learn moreReflecting on nearly 40 years of progress against pediatric brain tumors
| May 16, 2022May is Brain Tumor Awareness Month and a good time to learn more about the diverse group of diseases that make up the most common childhood solid tumor.
Learn moreYour Future, Your Decision: Tigers VAX Now HPV Vaccination Student Ambassador Program
| Jan 26, 2023The St. Jude HPV Cancer Prevention Program and the University of Memphis created Tigers VAX Now, a student ambassador program to empower college students to advocate for HPV vaccination as cancer prevention among their peers.
Learn morePowerful Voices: Preventing HPV Cancers through Survivor Perspectives
| Jan 12, 2023Participants in the St. Jude HPV Cancer Prevention Program’s HPV Cancer Survivors School are using their powerful voices to advocate for HPV vaccination during January which is Cervical Cancer Awareness Month.
Learn moreInvestigator Insights: Taking a Leap with Lily Guenther, MD
| Jan 5, 2023Sometimes a scientist’s next step isn’t a step, but more of a career-defining leap. Early-career investigator Lily Guenther, MD, shares her experience of taking that leap and starting a laboratory at St. Jude.
Learn more’Amazing effort’ brings Global Alliance to new heights at 2022 Convening
| Nov 10, 2022The 2022 St. Jude Global Alliance Convening brought together researchers from around the globe working to advance cures for children with catastrophic childhood diseases.
Learn moreGenetic predispositions can drive cancer but are not destiny for patients
| Jan 24, 2023Scientists at St. Jude are leading the way on understanding cancer predisposition and the way that inherited genetics can inform patient care.
Learn moreSt. Jude scientists on the hunt for ‘holy grail’ cancer vulnerabilities
| Jan 17, 2023Scientists at St. Jude Children’s Research Hospital are deploying genomic technologies to hunt for vulnerabilities in cancer.
Learn moreChildhood cancer genetics: A legacy of groundbreaking work drives St. Jude forward
| Jan 10, 2023St. Jude Children’s Research Hospital has a rich history of research on genetics stemming from the Pediatric Cancer Genome Project and reverberating through laboratories today.
Learn moreStudies of rare craniopharyngioma reveal ways to improve long-term outcomes for patients
| Nov 15, 2022A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.
Learn more